InBody Co.,Ltd (KOSDAQ:041830)
29,700
+1,050 (3.66%)
At close: Mar 20, 2026
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 362.11 billion as of March 20, 2026. Its market cap has increased by 11.66% in one year.
Market Cap
362.11B
Enterprise Value
272.14B
Revenue
226.62B
Ranking
n/a
PE Ratio
11.31
Stock Price
29,700.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 362.11B, an increase of 3,315.49%. That is a compound annual growth rate of 17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 362.11B | -9.31% |
| Dec 30, 2025 | 399.30B | 34.21% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seegene | 1.06T |
| Curexo | 625.80B |
| WON TECH | 622.56B |
| i-SENS | 576.53B |
| ToolGen | 427.99B |
| Bio Plus | 321.86B |
| DRTECH | 155.85B |
| T&R Biofab | 146.04B |